Corticosteroid Recommendations for Bell's Palsy in the Emergency Department
Immediate Treatment for Adults (≥16 Years)
Initiate oral corticosteroids within 72 hours of symptom onset—this is the only treatment window with proven efficacy. 1
Standard Dosing Regimens
Choose one of the following evidence-based regimens:
- Prednisolone 50 mg once daily for 10 days (no taper required), OR 1
- Prednisone 60 mg once daily for 5 days, followed by a 5-day taper 1
Both regimens demonstrate equivalent efficacy: 83% complete recovery at 3 months versus 63.6% with placebo (NNT = 6), and 94.4% recovery at 9 months versus 81.6% with placebo (NNT = 8). 1, 2, 3
Critical Timing Considerations
- Treatment initiated beyond 72 hours provides no proven benefit and should not be started. 1, 4 The clinical trials demonstrating steroid efficacy specifically enrolled patients within this window. 4
- Patients presenting at day 4 or later should receive supportive care only (eye protection) rather than corticosteroids. 4
Special Populations
Diabetic Patients
Diabetes is NOT a contraindication to corticosteroid therapy—the therapeutic benefit outweighs the risk of temporary hyperglycemia. 1
Glucose management protocol:
- Monitor capillary blood glucose every 2–4 hours during the first few days of treatment 1
- Administer steroids in the morning to align with natural cortisol rhythm 1
- For patients on basal insulin: increase the basal dose and add or increase prandial insulin 1
- For patients on oral agents only: add NPH insulin concurrent with the morning steroid dose (NPH peaks 4–6 hours later, matching steroid-induced hyperglycemia) 1
- Higher steroid doses may require substantial increases in both prandial and correctional insulin 1
Pregnant Patients
Prescribe oral corticosteroids within 72 hours using the same dosing regimens as non-pregnant adults. 1 While guidelines recommend "individualized assessment," the evidence supports treatment because:
- The 72-hour window for efficacy applies equally 1
- Eye protection measures are essential and safe in pregnancy 1
- The benefit of preventing permanent facial paralysis outweighs theoretical corticosteroid risks 1
Pediatric Patients (<16 Years)
Children have higher spontaneous recovery rates (up to 94%) than adults, and the benefit of corticosteroids in pediatrics is unproven. 1
Treatment algorithm for children:
- Incomplete paralysis: Observation only—recovery rates approach 94% without treatment 1
- Complete paralysis with presentation within 72 hours: Consider prednisolone 1 mg/kg/day (maximum 50–60 mg) for 5 days followed by a 5-day taper, but only after discussing with caregivers that pediatric benefit is uncertain 1
- Presentation beyond 72 hours: Supportive care only 1
Contraindications and Adjustments
Absolute Contraindications
Relative Contraindications Requiring Dose Adjustment
For patients significantly below or above average weight: Use weight-based dosing of 1 mg/kg/day prednisone (usual maximum 60 mg/day) to ensure adequate dosing across body sizes. 1
For patients with severe uncontrolled diabetes, active peptic ulcer, or severe osteoporosis: The guideline position is that the therapeutic benefit still outweighs risks for a 5–10 day course, but glucose monitoring and gastroprotection should be intensified. 1
Antiviral Therapy
Strong Recommendation Against Monotherapy
Never prescribe acyclovir or valacyclovir alone—antiviral monotherapy is completely ineffective for Bell's palsy. 1, 5, 2, 3
Optional Combination Therapy
Adding an antiviral to corticosteroids within 72 hours is optional and provides only a small incremental benefit. 1
Evidence for combination therapy:
- One small trial showed 96.5% recovery with steroids + acyclovir versus 89.7% with steroids alone (absolute benefit +6.8%) 1, 6
- However, the large BELLS trial (n=496) found no statistically significant advantage: 71.2% recovery with acyclovir versus 75.7% without (P=0.50) at 3 months 1, 2
- At 9 months: 85.4% with acyclovir versus 90.8% without 2, 3
If choosing combination therapy, use:
- Valacyclovir 1000 mg three times daily for 7 days, OR 1
- Acyclovir 400 mg five times daily for 10 days 1
The guideline classifies this as an "option" rather than a recommendation due to the minimal and inconsistent benefit. 1
Mandatory Eye Protection (All Patients with Incomplete Eye Closure)
Implement comprehensive eye protection immediately—corneal damage can occur within hours. 1
Daytime Protection
- Lubricating ophthalmic drops (e.g., hydroxypropyl methylcellulose) every 1–2 hours while awake 1
- Sunglasses outdoors to shield against wind and debris 1
Nighttime Protection
- Ophthalmic ointment at bedtime for sustained moisture 1
- Eye taping or patching with proper technique instruction to avoid corneal abrasion 1
- Consider moisture chambers using polyethylene covers for severe cases 1
Urgent Ophthalmology Referral Triggers
- Complete inability to close the eye 1
- Eye pain, vision changes, redness, discharge, or foreign body sensation 1
- Any signs of corneal exposure or damage 1
Interventions to Avoid
Do NOT order:
- Routine laboratory tests—they delay treatment without improving outcomes 1
- Routine imaging—reserve MRI for atypical presentations only 1
- Electrodiagnostic testing for incomplete paralysis—it provides no actionable information 1
- Physical therapy or acupuncture—no proven benefit over spontaneous recovery 1
- Surgical decompression—rarely indicated except in specialized centers 1
Mandatory Follow-Up and Referral Triggers
Refer to a facial nerve specialist if: 1
- Incomplete facial recovery at 3 months after symptom onset 1
- New or worsening neurologic findings at any point 1
- Development of ocular symptoms at any point 1
Red flags requiring immediate imaging (MRI with/without contrast): 1
- Recurrent paralysis on the same side 1
- Isolated branch paralysis 1
- Other cranial nerve involvement 1
- Progressive weakness beyond 3 weeks 1
- Bilateral facial weakness 1
Common Pitfalls
- Starting steroids beyond 72 hours: No evidence of benefit and exposes patients to medication risks 1, 4
- Prescribing antivirals alone: Completely ineffective and delays appropriate corticosteroid treatment 1, 5
- Inadequate eye protection: Can lead to permanent corneal damage, particularly in patients with complete paralysis 1
- Failing to refer at 3 months: Delays access to reconstructive options for the 30% who develop permanent weakness 1
- Withholding steroids in diabetics: The therapeutic benefit outweighs hyperglycemia risk for a 5–10 day course 1